Geng Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Geng Wang has a total of 168 co-authors. Here are the top co-authors by number of shared publications:
- David M. Evans
Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia
13 shared publications - Nicole M. Warrington
Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia
11 shared publications Nicole M Warrington
University of Queensland
7 shared publications- Bjørn Olav Åsvold
HUNT Center for Molecular and Clinical Epidemiology, Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway
6 shared publications - Ben Michael Brumpton
HUNT Center for Molecular and Clinical Epidemiology, Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway
5 shared publications - Gunn-Helen Moen
Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia
5 shared publications
Latest Publications
- Open Access
- 5 August 2026
- Published by Springer Nature in BMC Medicine
- Vol. 24 (1)
Effects of maternal and paternal smoking on offspring cardiometabolic risk factors in adulthood: a multi-method intergenerational Mendelian randomization study
Background: Parental smoking has been linked to several adverse offspring cardiometabolic outcomes; however, evidence is conflicting regarding the causal and long-term nature of these associations. Methods: We investigated the effects of maternal and paternal smoking, capturing exposure before, during, and after pregnancy, on eleven offspring cardiometabolic risk factors related to body composition, blood pressure, glucose, and lipid levels in adulthood. We applied a multi-method intergenerational Mendelian randomization (MR) framework, combining two-sample MR (outcome GWAS, n = up to 564,160) and one-sample MR analyses (n = up to 17,484 genotyped mother-father-offspring trios with offspring cardiometabolic risk factors) from the HUNT cohort, Norway, and the UK Biobank and ALSPAC cohorts in the United Kingdom. Smoking behaviour was instrumented using genome-wide significant variants for smoking initiation and heaviness from large genome-wide association studies (2019 and 2022), with additional analyses of the CHRNA5 variant rs16969968. Results: Using the two-sample MR approach, we found an average change in adult offspring waist-hip ratio (WHR) per one standard deviation (SD) increase in maternal cigarettes smoked per day of 0.25 SD (95% CI: 0.13, 0.38; 2019 GWAS), 0.19 SD (95% CI: 0.08, 0.31; 2022 GWAS) and 0.27 SD (95% CI: 0.07, 0.47; CHRNA5 rs16969968). We also found tentative evidence of comparable effects on offspring body mass index and C-reactive protein. One-sample MR analyses using CHRNA5 rs16969968, restricted to maternal ever-smokers, provided supporting evidence consistent with the primary findings for maternal smoking heaviness on offspring WHR. We found little evidence that maternal smoking initiation affected WHR, and little evidence that maternal smoking heaviness affected the remaining cardiometabolic risk factors; paternal smoking showed no clear effect on any outcome. Results from sensitivity analyses were consistent with these main findings. Conclusions: Adult offspring of mothers with a propensity to heavier smoking exhibited greater central adiposity, a phenotype associated with increased cardiometabolic risk. These findings are consistent with a causal influence of maternal smoking heaviness across the preconception, perinatal, and postnatal periods on later-life offspring body fat distribution. Further triangulation using alternative causal approaches is warranted.
- 5 August 2026
- Published by Springer Nature in BMC Medicine
- Vol. 24 (1)
Open AccessEffects of maternal and paternal smoking on offspring cardiometabolic risk factors in adulthood: a multi-method intergenerational Mendelian randomization study
Background: Parental smoking has been linked to several adverse offspring cardiometabolic outcomes; however, evidence is conflicting regarding the causal and long-term nature of these associations. Methods: We investigated the effects of maternal and paternal smoking, capturing exposure before, during, and after pregnancy, on eleven offspring cardiometabolic risk factors related to body composition, blood pressure, glucose, and lipid levels in adulthood. We applied a multi-method intergenerational Mendelian randomization (MR) framework, combining two-sample MR (outcome GWAS, n = up to 564,160) and one-sample MR analyses (n = up to 17,484 genotyped mother-father-offspring trios with offspring cardiometabolic risk factors) from the HUNT cohort, Norway, and the UK Biobank and ALSPAC cohorts in the United Kingdom. Smoking behaviour was instrumented using genome-wide significant variants for smoking initiation and heaviness from large genome-wide association studies (2019 and 2022), with additional analyses of the CHRNA5 variant rs16969968. Results: Using the two-sample MR approach, we found an average change in adult offspring waist-hip ratio (WHR) per one standard deviation (SD) increase in maternal cigarettes smoked per day of 0.25 SD (95% CI: 0.13, 0.38; 2019 GWAS), 0.19 SD (95% CI: 0.08, 0.31; 2022 GWAS) and 0.27 SD (95% CI: 0.07, 0.47; CHRNA5 rs16969968). We also found tentative evidence of comparable effects on offspring body mass index and C-reactive protein. One-sample MR analyses using CHRNA5 rs16969968, restricted to maternal ever-smokers, provided supporting evidence consistent with the primary findings for maternal smoking heaviness on offspring WHR. We found little evidence that maternal smoking initiation affected WHR, and little evidence that maternal smoking heaviness affected the remaining cardiometabolic risk factors; paternal smoking showed no clear effect on any outcome. Results from sensitivity analyses were consistent with these main findings. Conclusions: Adult offspring of mothers with a propensity to heavier smoking exhibited greater central adiposity, a phenotype associated with increased cardiometabolic risk. These findings are consistent with a causal influence of maternal smoking heaviness across the preconception, perinatal, and postnatal periods on later-life offspring body fat distribution. Further triangulation using alternative causal approaches is warranted.
- Open Access
- 19 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 1594
Distinct genetic profiles influence body mass index between infancy and adolescence
Body mass index (BMI) changes throughout life with age-varying genetic contributions. We use a random regression model to investigate the genetic contribution to BMI trajectories from ages one to 18 years in 6,291 ALSPAC participants with 65,930 repeated BMI measurements. Here we show the estimated SNP-based heritability of BMI at 9.5 years is 28.4% (SE = 4.8%), and 23.8% (SE = 4.2%) for rate of change in BMI from one to 18 years. The genetic correlations between early childhood and adolescence are low (genetic correlation between two and 17 years is 0.108 [SE = 0.146]). We find that the first principal component of the trajectory, explaining 89% of genetic variation, captures effects which increase in magnitude from early childhood to adolescence and then plateau. A second axis explaining 9% of the genetic variance has opposite effects on BMI between early and later ages. Our findings demonstrate the value of RRMs to reveal age-specific genetic influences on BMI across development.
- 19 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 1594
Open AccessDistinct genetic profiles influence body mass index between infancy and adolescence
Body mass index (BMI) changes throughout life with age-varying genetic contributions. We use a random regression model to investigate the genetic contribution to BMI trajectories from ages one to 18 years in 6,291 ALSPAC participants with 65,930 repeated BMI measurements. Here we show the estimated SNP-based heritability of BMI at 9.5 years is 28.4% (SE = 4.8%), and 23.8% (SE = 4.2%) for rate of change in BMI from one to 18 years. The genetic correlations between early childhood and adolescence are low (genetic correlation between two and 17 years is 0.108 [SE = 0.146]). We find that the first principal component of the trajectory, explaining 89% of genetic variation, captures effects which increase in magnitude from early childhood to adolescence and then plateau. A second axis explaining 9% of the genetic variance has opposite effects on BMI between early and later ages. Our findings demonstrate the value of RRMs to reveal age-specific genetic influences on BMI across development.
- Open Access
Effects of maternal and paternal smoking on offspring cardiometabolic risk factors in adulthood: a multi-method intergenerational Mendelian randomization study
Parental smoking has been linked to several adverse offspring cardiometabolic outcomes; however, evidence is conflicting regarding the causal and long-term nature of these associations. We investigated the effects of maternal and paternal smoking, capturing exposure before, during, and after pregnancy, on eleven offspring cardiometabolic risk factors related to body composition, blood pressure, glucose, and lipid levels in adulthood. We applied a multi-method intergenerational Mendelian randomization (MR) framework, combining two-sample MR (outcome GWAS n = up to 564,160) and one-sample MR using genetic risk score (GRS) analyses (n = up to 17,484 genotyped mother, father, offspring trios with offspring cardiometabolic risk factors) from the Norwegian HUNT cohort and British UK Biobank and ALSPAC cohorts. Smoking behaviour was instrumented using genome-wide significant variants for smoking initiation and heaviness from large genome-wide association studies (2019 and 2022), with additional analyses of the CHRNA5 variant rs16969968. Using the two-sample MR approach, we found that an average change in adult offspring waist-hip-ratio (WHR) per one standard deviation (SD) increase in maternal cigarettes smoked per day of 0.25 SD (95% CI: 0.13, 0.38; 2019 GWAS), 0.19 SD (95% CI: 0.08, 0.31; 2022 GWAS) and 0.27 SD (95% CI: 0.07, 0.47; CHRNA5 rs16969968). We also found tentative evidence of comparable effects on offspring body mass index and C-reactive protein. One-sample MR analyses using CHRNA5 rs16969968, restricted to maternal ever-smokers, provided supporting evidence for a causal effect of maternal smoking heaviness on offspring WHR. We found little evidence that maternal smoking initiation affected WHR, and little evidence that maternal smoking heaviness affected the remaining cardiometabolic risk factors; paternal smoking showed no clear effect on any outcome. Results from sensitivity analyses were consistent with these main findings. Our finding of higher central adiposity in adult offspring of mothers with a propensity to smoke more heavily provides further incentive for prospective mothers to quit or reduce smoking heaviness before, during, and after pregnancy. Triangulating these findings using alternative methods would be valuable.
Open AccessEffects of maternal and paternal smoking on offspring cardiometabolic risk factors in adulthood: a multi-method intergenerational Mendelian randomization study
Parental smoking has been linked to several adverse offspring cardiometabolic outcomes; however, evidence is conflicting regarding the causal and long-term nature of these associations. We investigated the effects of maternal and paternal smoking, capturing exposure before, during, and after pregnancy, on eleven offspring cardiometabolic risk factors related to body composition, blood pressure, glucose, and lipid levels in adulthood. We applied a multi-method intergenerational Mendelian randomization (MR) framework, combining two-sample MR (outcome GWAS n = up to 564,160) and one-sample MR using genetic risk score (GRS) analyses (n = up to 17,484 genotyped mother, father, offspring trios with offspring cardiometabolic risk factors) from the Norwegian HUNT cohort and British UK Biobank and ALSPAC cohorts. Smoking behaviour was instrumented using genome-wide significant variants for smoking initiation and heaviness from large genome-wide association studies (2019 and 2022), with additional analyses of the CHRNA5 variant rs16969968. Using the two-sample MR approach, we found that an average change in adult offspring waist-hip-ratio (WHR) per one standard deviation (SD) increase in maternal cigarettes smoked per day of 0.25 SD (95% CI: 0.13, 0.38; 2019 GWAS), 0.19 SD (95% CI: 0.08, 0.31; 2022 GWAS) and 0.27 SD (95% CI: 0.07, 0.47; CHRNA5 rs16969968). We also found tentative evidence of comparable effects on offspring body mass index and C-reactive protein. One-sample MR analyses using CHRNA5 rs16969968, restricted to maternal ever-smokers, provided supporting evidence for a causal effect of maternal smoking heaviness on offspring WHR. We found little evidence that maternal smoking initiation affected WHR, and little evidence that maternal smoking heaviness affected the remaining cardiometabolic risk factors; paternal smoking showed no clear effect on any outcome. Results from sensitivity analyses were consistent with these main findings. Our finding of higher central adiposity in adult offspring of mothers with a propensity to smoke more heavily provides further incentive for prospective mothers to quit or reduce smoking heaviness before, during, and after pregnancy. Triangulating these findings using alternative methods would be valuable.
- Open Access
- 14 July 2025
- Published by Springer Nature in Research Square
Multi-omic insights from a multi-ancestry genome-wide meta-analysis of ankylosing spondylitis reveal novel pathways of disease susceptibility
We report the largest genome-wide association study meta-analysis in ankylosing spondylitis (AS) to date (25,645 cases, 71,224 controls), identifying 27 novel loci and 86 independent genetic associations. Variations in FUT2 (non-secretor status) and ABO (blood group A) increase AS risk, with Mendelian randomisation (MR) linking non-secretor status to increased AS risk from reduced gut carriage of Ruminococcus torques. Associations with three telomerase maintenance genes (TERT, TERC, RTEL1), and MR analysis, suggest increased telomere length causally increases AS susceptibility. Fine-mapping prioritised likely causal variants at multiple loci. Transcriptome- and proteome-wide association studies implicated 644 genes, highlighting immune-related pathways. Lower genetically-determined IL-6 and IL-12, and similar IL-23, levels were found in AS cases, offering a genetic explanation for the failure of IL-6, IL-12, and IL-23 inhibition in AS treatment. Finally, multi-omic analyses showed chromosome 2p15 association acts via reduced B3GNT2 expression. These findings deepen understanding of AS pathogenesis, highlighting new pathways and therapeutic opportunities.
- 14 July 2025
- Published by Springer Nature in Research Square
Open AccessMulti-omic insights from a multi-ancestry genome-wide meta-analysis of ankylosing spondylitis reveal novel pathways of disease susceptibility
We report the largest genome-wide association study meta-analysis in ankylosing spondylitis (AS) to date (25,645 cases, 71,224 controls), identifying 27 novel loci and 86 independent genetic associations. Variations in FUT2 (non-secretor status) and ABO (blood group A) increase AS risk, with Mendelian randomisation (MR) linking non-secretor status to increased AS risk from reduced gut carriage of Ruminococcus torques. Associations with three telomerase maintenance genes (TERT, TERC, RTEL1), and MR analysis, suggest increased telomere length causally increases AS susceptibility. Fine-mapping prioritised likely causal variants at multiple loci. Transcriptome- and proteome-wide association studies implicated 644 genes, highlighting immune-related pathways. Lower genetically-determined IL-6 and IL-12, and similar IL-23, levels were found in AS cases, offering a genetic explanation for the failure of IL-6, IL-12, and IL-23 inhibition in AS treatment. Finally, multi-omic analyses showed chromosome 2p15 association acts via reduced B3GNT2 expression. These findings deepen understanding of AS pathogenesis, highlighting new pathways and therapeutic opportunities.
- Open Access
Exploring the effect of maternal glycemic traits on offspring cardiometabolic risk factors in adulthood: an intergenerational Mendelian randomization study
Introduction: Maternal higher circulating glucose levels in pregnancy have been proposed to influence the offspring’s cardiometabolic health in adulthood through developmental mechanisms. Previous observational studies may have been subject to confounding, including by the inheritance of maternal alleles that predispose to hyperglycemia in the offspring. Objectives: We aimed to test the causal effect of maternal glycemic traits on offspring cardiometabolic risk factors in adulthood. Methods: Two-sample intergenerational Mendelian randomization (MR) analyses were performed. Exposures in these MR analyses were maternal fasting glucose, type 2 diabetes, and gestational diabetes. Similar paternal exposures were used as negative controls. Single Nucleotide Polymorphism (SNP)-exposure associations were obtained from recent genome-wide association studies (GWAS) of fasting glucose (61 SNPs), type 2 diabetes (210 SNPs) and gestational diabetes (8 SNPs). SNP-outcome associations were obtained from adjusted GWAS (parental genotype adjusted for offspring genotype) of adult cardiovascular outcomes which we undertook in three European cohorts (n=up to 566,132). Outcomes in these MR analyses were offspring body mass index, waist-to-hip ratio, systolic and diastolic blood pressure, blood glucose, HbA1c, total cholesterol, low- and high-density lipoprotein cholesterol, triglycerides, and C-reactive protein, measured at 24-62 years of age. Birthweight was used as a positive control. Results: The crude observed positive association between maternal glycemic traits and offspring blood glucose and HbA1c completely attenuated to the null after adjusting for the offsprinǵs genotype. We found no strong evidence that higher maternal fasting glucose, type 2 diabetes, or gestational diabetes were causal for adult offspring cardiometabolic risk factors. For example, the MR analyses suggested that 1SD greater maternal fasting glucose resulted in a 0.088 (95% CI: −0.090, 0.267; P =0.331) SD difference in mean offspring BMI. Results were similar for type 2 diabetes (−0.007 SD change in BMI per unit increase in log odds; 95% CI: - 0.043, 0.030; P =0.726) and gestational diabetes (−0.016 SD change in BMI per unit increase in log odds; 95% CI: −0.105, 0.072; P =0.716). In contrast, we found strong evidence that higher maternal (but not paternal) fasting glucose, type 2 diabetes, and gestational diabetes were causal for increased offspring birthweight. Conclusions: Our data suggest that maternal glucose levels do not have a major influence on offspring cardiometabolic risk factors in adulthood.
Open AccessExploring the effect of maternal glycemic traits on offspring cardiometabolic risk factors in adulthood: an intergenerational Mendelian randomization study
Introduction: Maternal higher circulating glucose levels in pregnancy have been proposed to influence the offspring’s cardiometabolic health in adulthood through developmental mechanisms. Previous observational studies may have been subject to confounding, including by the inheritance of maternal alleles that predispose to hyperglycemia in the offspring. Objectives: We aimed to test the causal effect of maternal glycemic traits on offspring cardiometabolic risk factors in adulthood. Methods: Two-sample intergenerational Mendelian randomization (MR) analyses were performed. Exposures in these MR analyses were maternal fasting glucose, type 2 diabetes, and gestational diabetes. Similar paternal exposures were used as negative controls. Single Nucleotide Polymorphism (SNP)-exposure associations were obtained from recent genome-wide association studies (GWAS) of fasting glucose (61 SNPs), type 2 diabetes (210 SNPs) and gestational diabetes (8 SNPs). SNP-outcome associations were obtained from adjusted GWAS (parental genotype adjusted for offspring genotype) of adult cardiovascular outcomes which we undertook in three European cohorts (n=up to 566,132). Outcomes in these MR analyses were offspring body mass index, waist-to-hip ratio, systolic and diastolic blood pressure, blood glucose, HbA1c, total cholesterol, low- and high-density lipoprotein cholesterol, triglycerides, and C-reactive protein, measured at 24-62 years of age. Birthweight was used as a positive control. Results: The crude observed positive association between maternal glycemic traits and offspring blood glucose and HbA1c completely attenuated to the null after adjusting for the offsprinǵs genotype. We found no strong evidence that higher maternal fasting glucose, type 2 diabetes, or gestational diabetes were causal for adult offspring cardiometabolic risk factors. For example, the MR analyses suggested that 1SD greater maternal fasting glucose resulted in a 0.088 (95% CI: −0.090, 0.267; P =0.331) SD difference in mean offspring BMI. Results were similar for type 2 diabetes (−0.007 SD change in BMI per unit increase in log odds; 95% CI: - 0.043, 0.030; P =0.726) and gestational diabetes (−0.016 SD change in BMI per unit increase in log odds; 95% CI: −0.105, 0.072; P =0.716). In contrast, we found strong evidence that higher maternal (but not paternal) fasting glucose, type 2 diabetes, and gestational diabetes were causal for increased offspring birthweight. Conclusions: Our data suggest that maternal glucose levels do not have a major influence on offspring cardiometabolic risk factors in adulthood.
- Open Access
Parental body mass index and offspring cardiovascular risk factors in adulthood: an intergenerational Mendelian randomization study
Importance: Observationally, greater pre-pregnancy maternal and paternal body mass index (BMI) are associated with a poorer offspring adult cardiovascular risk factor profile, but it is unclear whether this is due to family-level confounding or causal developmental mechanisms. Objective: We aimed to test the causal effect of maternal and paternal BMI on offspring cardiovascular risk factors in adulthood, accounting for the genetic correlation between parents and offspring. Design: Two-sample intergenerational Mendelian randomization (MR) study. Genetic instruments for parental BMI (up to 495 SNPs) were obtained from the most recent genome wide association study (GWAS). Genetic associations were extracted from adjusted GWAS (parental genotype adjusted for offspring genotype) of adult cardiovascular outcomes, which we undertook in the Trøndelag Health Study (HUNT), UK Biobank (UKB) and the Avon Longitudinal Study of Parents and Children (ALSPAC) ( n = up to 564,160). We conducted sensitivity analyses that are robust to different patterns of horizontal pleiotropy. Setting: Norway (HUNT; MoBa) and UK (UKB and ALSPAC). Exposures: Maternal and paternal BMI. Main outcomes: Offspring BMI, waist-hip ratio (WHR), systolic (SBP) and diastolic (DBP) blood pressure, glucose, glycated haemoglobin (HbA1c), cholesterol, HDL-C, LDL-C, triglycerides, and C-reactive protein (CRP), measured at 24-62 years of age. Offspring birth weight was included as a positive control outcome for which we would expect to find a causal effect from maternal BMI. Results: MR provided little evidence for a causal effect of maternal or paternal BMI on offspring outcomes. Differences (95% CI, P -value) in mean outcome standard deviation (SD) per 1 SD higher maternal BMI were −0.04 (−0.11, 0.04, P = 0.31) for BMI, 0.01 (−0.05, 0.06, P = 0.85) for SBP and 0.02 (−0.04, 0.09, P = 0.47) for glucose. Equivalent paternal results were 0.00 (−0.08, 0.09, P = 0.97) for BMI, −0.01 (−0.07, 0.06, P = 0.85) for SBP, and −0.05 (−0.13, 0.03, P = 0.24) for glucose. Results for other outcomes were similar, and sensitivity analyses were consistent. For birth weight, we found strong evidence for a causal effect of maternal BMI (0.10 [0.05, 0.14, P = 3.7×10 −6 ]), but not paternal BMI (0.01 [−0.06, 0.07, P = 0.87]). Conclusions and relevance: Our data suggest that neither maternal nor paternal BMI have a major influence on offspring adult cardiovascular risk factors.
Open AccessParental body mass index and offspring cardiovascular risk factors in adulthood: an intergenerational Mendelian randomization study
Importance: Observationally, greater pre-pregnancy maternal and paternal body mass index (BMI) are associated with a poorer offspring adult cardiovascular risk factor profile, but it is unclear whether this is due to family-level confounding or causal developmental mechanisms. Objective: We aimed to test the causal effect of maternal and paternal BMI on offspring cardiovascular risk factors in adulthood, accounting for the genetic correlation between parents and offspring. Design: Two-sample intergenerational Mendelian randomization (MR) study. Genetic instruments for parental BMI (up to 495 SNPs) were obtained from the most recent genome wide association study (GWAS). Genetic associations were extracted from adjusted GWAS (parental genotype adjusted for offspring genotype) of adult cardiovascular outcomes, which we undertook in the Trøndelag Health Study (HUNT), UK Biobank (UKB) and the Avon Longitudinal Study of Parents and Children (ALSPAC) ( n = up to 564,160). We conducted sensitivity analyses that are robust to different patterns of horizontal pleiotropy. Setting: Norway (HUNT; MoBa) and UK (UKB and ALSPAC). Exposures: Maternal and paternal BMI. Main outcomes: Offspring BMI, waist-hip ratio (WHR), systolic (SBP) and diastolic (DBP) blood pressure, glucose, glycated haemoglobin (HbA1c), cholesterol, HDL-C, LDL-C, triglycerides, and C-reactive protein (CRP), measured at 24-62 years of age. Offspring birth weight was included as a positive control outcome for which we would expect to find a causal effect from maternal BMI. Results: MR provided little evidence for a causal effect of maternal or paternal BMI on offspring outcomes. Differences (95% CI, P -value) in mean outcome standard deviation (SD) per 1 SD higher maternal BMI were −0.04 (−0.11, 0.04, P = 0.31) for BMI, 0.01 (−0.05, 0.06, P = 0.85) for SBP and 0.02 (−0.04, 0.09, P = 0.47) for glucose. Equivalent paternal results were 0.00 (−0.08, 0.09, P = 0.97) for BMI, −0.01 (−0.07, 0.06, P = 0.85) for SBP, and −0.05 (−0.13, 0.03, P = 0.24) for glucose. Results for other outcomes were similar, and sensitivity analyses were consistent. For birth weight, we found strong evidence for a causal effect of maternal BMI (0.10 [0.05, 0.14, P = 3.7×10 −6 ]), but not paternal BMI (0.01 [−0.06, 0.07, P = 0.87]). Conclusions and relevance: Our data suggest that neither maternal nor paternal BMI have a major influence on offspring adult cardiovascular risk factors.
- Open Access
Examining the association between fetal HLA-C , maternal KIR haplotypes and birth weight
Human birth weight is under stabilizing selection, seeking balance between extremes of high and low, thereby reducing fetal and maternal perinatal mortality risk. Certain combinations of maternal killer immunoglobulin-like receptor ( KIR ) and paternally derived fetal human leuokocyte antigen-C ( HLA-C ) alleles were previously associated with higher risk of high and low birth weight in a study with limited sample size (n=1,316). Using recently developed methods to impute HLA and KIR haplotypes using single nucleotide polymorphism (SNP) genotype data, we tested associations of fetal HLA and maternal KIR genotypes with offspring birth weight in a large sample. We imputed KIR haplotypes using the KIR*IMP imputation software in 10,602 mother-offspring pairs of European descent from singleton pregnancies from five studies. Using mixed linear regression models to account for mothers with multiple children, we tested associations between maternal KIR A vs B haplotypes ( AA, AB/BA, BB genotypes) as well as copy number of activating receptor gene KIR2DS1 (0, 1, 2 copies of the gene) in the presence of fetal HLA C1/C2 alleles, and offspring birth weight. Associations were analyzed in each cohort before performing a meta-analysis to estimate the interaction effects between maternal KIR and fetal HLA-C2 on birth weight across the entire sample. The KIR haplotypes achieved imputation accuracy estimated at >95% in most of the cohorts. No interaction effects were observed between either the maternal A vs. B haplotype or the maternal KIR2DS1 locus and fetal HLA-C . When specifically trying to replicate the previously associated combination of maternal KIR2DS1 and paternally inherited fetal HLA-C2 , there was a negligible change in offspring birth weight for each additional KIR2DS1 allele and HLA-C2 of paternal origin (7g lower birth weight per allele [95% CI: -54, 40], P = 0.78). We found little evidence of association between birth weight and maternal KIR haplotypes or fetal HLA-C2 and were unable to replicate previously reported findings. Our observations reinforce the importance of replication and the use of large sample sizes in the validation of genetic associations. Author Summary: Babies born with very high or low birth weights and their mothers are at a higher risk of illness and death than babies with weights close to average. Genes involved in the maternal immune system, called “ KIR ”, and the fetal immune system, called “ HLA-C ”, are important for early development of the placenta. Previously published research using a small sample has provided evidence for the role of interacting combinations of these genes in driving the spectrum of birth weight and maintaining the balancing selection of mother-child physiology that results in healthy birth outcomes. Here we harness recently developed methods to impute these genetic data to test associations of maternal KIR and fetal HLA with child’s birth weight in a larger sample. By examining >10,000 European ancestry mother-child pairs, we found no relationship between child’s birth weight and any of the genetic combinations we tested of KIR in the mother and HLA-C in the fetus. We show that despite biological plausibility, it is important to validate genetic associations through replication and using the largest sample sizes possible. Future research could benefit from including birth weights in the true extremes of the spectrum, using methods such as high throughput genome sequencing technologies which could provide more accurate data for these gene regions on a larger scale, and investigation in ancestrally diverse populations.
Open AccessExamining the association between fetal HLA-C , maternal KIR haplotypes and birth weight
Human birth weight is under stabilizing selection, seeking balance between extremes of high and low, thereby reducing fetal and maternal perinatal mortality risk. Certain combinations of maternal killer immunoglobulin-like receptor ( KIR ) and paternally derived fetal human leuokocyte antigen-C ( HLA-C ) alleles were previously associated with higher risk of high and low birth weight in a study with limited sample size (n=1,316). Using recently developed methods to impute HLA and KIR haplotypes using single nucleotide polymorphism (SNP) genotype data, we tested associations of fetal HLA and maternal KIR genotypes with offspring birth weight in a large sample. We imputed KIR haplotypes using the KIR*IMP imputation software in 10,602 mother-offspring pairs of European descent from singleton pregnancies from five studies. Using mixed linear regression models to account for mothers with multiple children, we tested associations between maternal KIR A vs B haplotypes ( AA, AB/BA, BB genotypes) as well as copy number of activating receptor gene KIR2DS1 (0, 1, 2 copies of the gene) in the presence of fetal HLA C1/C2 alleles, and offspring birth weight. Associations were analyzed in each cohort before performing a meta-analysis to estimate the interaction effects between maternal KIR and fetal HLA-C2 on birth weight across the entire sample. The KIR haplotypes achieved imputation accuracy estimated at >95% in most of the cohorts. No interaction effects were observed between either the maternal A vs. B haplotype or the maternal KIR2DS1 locus and fetal HLA-C . When specifically trying to replicate the previously associated combination of maternal KIR2DS1 and paternally inherited fetal HLA-C2 , there was a negligible change in offspring birth weight for each additional KIR2DS1 allele and HLA-C2 of paternal origin (7g lower birth weight per allele [95% CI: -54, 40], P = 0.78). We found little evidence of association between birth weight and maternal KIR haplotypes or fetal HLA-C2 and were unable to replicate previously reported findings. Our observations reinforce the importance of replication and the use of large sample sizes in the validation of genetic associations. Author Summary: Babies born with very high or low birth weights and their mothers are at a higher risk of illness and death than babies with weights close to average. Genes involved in the maternal immune system, called “ KIR ”, and the fetal immune system, called “ HLA-C ”, are important for early development of the placenta. Previously published research using a small sample has provided evidence for the role of interacting combinations of these genes in driving the spectrum of birth weight and maintaining the balancing selection of mother-child physiology that results in healthy birth outcomes. Here we harness recently developed methods to impute these genetic data to test associations of maternal KIR and fetal HLA with child’s birth weight in a larger sample. By examining >10,000 European ancestry mother-child pairs, we found no relationship between child’s birth weight and any of the genetic combinations we tested of KIR in the mother and HLA-C in the fetus. We show that despite biological plausibility, it is important to validate genetic associations through replication and using the largest sample sizes possible. Future research could benefit from including birth weights in the true extremes of the spectrum, using methods such as high throughput genome sequencing technologies which could provide more accurate data for these gene regions on a larger scale, and investigation in ancestrally diverse populations.
- Open Access
- 9 December 2024
- Published by Springer Nature in Behavior Genetics
- Vol. 55 (2) , 86-102
No Evidence of Interaction Between FADS2 Genotype and Breastfeeding on Cognitive or Other Traits in the UK Biobank
Breastfeeding is hypothesised to benefit child health and cognitive functioning by providing long-chain polyunsaturated fatty acids, which are essential for brain development. In 2007, Caspi et al. found evidence in two cohorts for an interaction between genetic variation in the FADS2 gene (a gene involved in fatty acid metabolism) and breastfeeding on IQ. However, subsequent studies have provided mixed evidence for the existence of an interaction. We investigated the relationship between genetic variation in the FADS2 region, breastfeeding, and their interaction in up to 335,650 individuals from the UK Biobank. We tested for the interaction over a range of cognitive functioning tests, as well as educational attainment and other traits thought to be influenced by breastfeeding, including cardiometabolic traits, number of offspring, and atopic allergy. FADS2 alleles associated with an increase in docosahexaenoic acid in blood serum (the C allele of rs174575) were associated with decreased verbal-numerical reasoning ( $$p=2.28\times {10}^{-5}$$ ) and triglycerides ( $$p=1.40\times {10}^{-41}$$ ), increased number of offspring ( $$p=3.40\times {10}^{-5}$$ ), total cholesterol ( $$p=5.28\times {10}^{-36}$$ ), HDL ( $$p=1.42\times {10}^{-51}$$ ), and LDL cholesterol ( $$p=1.46\times {10}^{-21}$$ ). We observed no evidence of an interaction in any of the traits, regardless of the modelling strategy on any cognitive or non-cognitive traits. We postulate that the previous positive findings are likely to be spurious, perhaps due to lack of appropriate control for latent population structure.- 9 December 2024
- Published by Springer Nature in Behavior Genetics
- Vol. 55 (2) , 86-102
Open AccessNo Evidence of Interaction Between FADS2 Genotype and Breastfeeding on Cognitive or Other Traits in the UK Biobank
Breastfeeding is hypothesised to benefit child health and cognitive functioning by providing long-chain polyunsaturated fatty acids, which are essential for brain development. In 2007, Caspi et al. found evidence in two cohorts for an interaction between genetic variation in the FADS2 gene (a gene involved in fatty acid metabolism) and breastfeeding on IQ. However, subsequent studies have provided mixed evidence for the existence of an interaction. We investigated the relationship between genetic variation in the FADS2 region, breastfeeding, and their interaction in up to 335,650 individuals from the UK Biobank. We tested for the interaction over a range of cognitive functioning tests, as well as educational attainment and other traits thought to be influenced by breastfeeding, including cardiometabolic traits, number of offspring, and atopic allergy. FADS2 alleles associated with an increase in docosahexaenoic acid in blood serum (the C allele of rs174575) were associated with decreased verbal-numerical reasoning ( $$p=2.28\times {10}^{-5}$$ ) and triglycerides ( $$p=1.40\times {10}^{-41}$$ ), increased number of offspring ( $$p=3.40\times {10}^{-5}$$ ), total cholesterol ( $$p=5.28\times {10}^{-36}$$ ), HDL ( $$p=1.42\times {10}^{-51}$$ ), and LDL cholesterol ( $$p=1.46\times {10}^{-21}$$ ). We observed no evidence of an interaction in any of the traits, regardless of the modelling strategy on any cognitive or non-cognitive traits. We postulate that the previous positive findings are likely to be spurious, perhaps due to lack of appropriate control for latent population structure. - Open Access
- 3 October 2024
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 45 (45) , 4865-4866
Is lower birthweight truly causal for increased cardiovascular risk?
This commentary refers to ‘Birth weight influences cardiac structure, function, and disease risk: evidence of a causal association’, by M. Ardissino et al., https://doi.org/10.1093/eurheartj/ehad631 and the discussion piece ‘Genetic analyses of birthweight and cardiovascular disease’, by M. Ardissino et al., https://doi.org/10.1093/eurheartj/ehae510.
- 3 October 2024
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 45 (45) , 4865-4866
Open AccessIs lower birthweight truly causal for increased cardiovascular risk?
This commentary refers to ‘Birth weight influences cardiac structure, function, and disease risk: evidence of a causal association’, by M. Ardissino et al., https://doi.org/10.1093/eurheartj/ehad631 and the discussion piece ‘Genetic analyses of birthweight and cardiovascular disease’, by M. Ardissino et al., https://doi.org/10.1093/eurheartj/ehae510.
- Open Access
- 29 August 2024
- Published by Springer Nature in Research Square
Distinct genetic profiles influence body mass index between infancy and adolescence
Body mass index (BMI) changes throughout life with age-varying genetic contributions. We investigated the genetic contribution to BMI across early life using repeated measures from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort. Random regression modelling was used to estimate the genetic covariance matrix ( Kg ) of BMI trajectories from ages one to 18 years with 65,930 repeated BMI measurements from 6,291 genotyped ALSPAC participants. The Kg matrix was used to estimate SNP-based heritability (\(\:{h}_{SNP}^{2}\)) from 1–18 years and genetic correlations across early life. Eigenvalue decomposition of Kg further identified age-varying genetic patterns of BMI. Finally, we investigated the impact of a polygenic score of adult BMI on the estimated genetic components across early life. The \(\:{h}_{SNP}^{2}\) was relatively constant across early life, between 23–30%. The genetic contribution to BMI in early childhood is different to that in later childhood, indicated by the diminishing genetic correlation across different ages. The eigenvalue decomposition revealed that the primary axis of variation (explaining 89% of the genetic variance in Kg ) increases with age from zero and reaches a plateau in adolescence, while the second eigenfunction (explaining around 9% of Kg ) represents factors with opposing effects on BMI between early and later ages. Adjusting for the adult BMI polygenic score attenuated the \(\:{h}_{SNP}^{2}\) from late childhood; for example, \(\:{h}_{SNP}^{2}\) is 29.8% (SE = 6.5%) at 18 years of age and attenuates to 14.5% (SE = 6.3%) after the adjustment. Our findings indicate that there is a different genetic profile operating during infancy compared to later childhood and adolescence.- 29 August 2024
- Published by Springer Nature in Research Square
Open AccessDistinct genetic profiles influence body mass index between infancy and adolescence
Body mass index (BMI) changes throughout life with age-varying genetic contributions. We investigated the genetic contribution to BMI across early life using repeated measures from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort. Random regression modelling was used to estimate the genetic covariance matrix ( Kg ) of BMI trajectories from ages one to 18 years with 65,930 repeated BMI measurements from 6,291 genotyped ALSPAC participants. The Kg matrix was used to estimate SNP-based heritability (\(\:{h}_{SNP}^{2}\)) from 1–18 years and genetic correlations across early life. Eigenvalue decomposition of Kg further identified age-varying genetic patterns of BMI. Finally, we investigated the impact of a polygenic score of adult BMI on the estimated genetic components across early life. The \(\:{h}_{SNP}^{2}\) was relatively constant across early life, between 23–30%. The genetic contribution to BMI in early childhood is different to that in later childhood, indicated by the diminishing genetic correlation across different ages. The eigenvalue decomposition revealed that the primary axis of variation (explaining 89% of the genetic variance in Kg ) increases with age from zero and reaches a plateau in adolescence, while the second eigenfunction (explaining around 9% of Kg ) represents factors with opposing effects on BMI between early and later ages. Adjusting for the adult BMI polygenic score attenuated the \(\:{h}_{SNP}^{2}\) from late childhood; for example, \(\:{h}_{SNP}^{2}\) is 29.8% (SE = 6.5%) at 18 years of age and attenuates to 14.5% (SE = 6.3%) after the adjustment. Our findings indicate that there is a different genetic profile operating during infancy compared to later childhood and adolescence.